Ann: Key Day 100 Survival Results In P3 GvHD Trial, page-5

  1. 6,159 Posts.
    lightbulb Created with Sketch. 1096
    What a magnificent event to present these wonderful numbers to the biggest stem cell event in the world.

    http://www.isscr.org/meetings-event...meeting-2018/program/2018-program-book-errata

    2018 ISSR Annual Meeting

    20-23 June, 2018
    Melbourne Convention & Exhibition Centre
    Melbourne, Australia


    Wednesday, 20 June

    Plenary II: Recapitulating Development from Stem Cells 16:00-18:00
    Nissim Benvenisty, Hebrew University, Israel
    HAPLOID HUMAN EMBRYONIC STEM CELLS: DERIVATION AND APPLICATIONS

    Thursday, 21 June
    Concurrent IA: Mechanisms of Reprogramming 1: to pluripotency (13:15 to 15:15)
    14:30 - 14:45 Abstract-selected speaker
    Jian Shu, Broad Institute/Whitehead Institute, MA, U.S.
    RECONSTRUCTION OF CELLULAR REPROGRAMMING LANDSCAPES AND TRAJECTORIES BY ANALYSIS OF LARGE-SCALE SINGLE-CELL GENE EXPRESSION

    Concurrent IE: Homeostasis, Metabolism and Aging (13:15 to 15:15)
    Session Chair: Amy Wagers, Harvard University, U.S.
    13:15 – 13:20 Topic Overview by Chair

    Concurrent IIC: Road to the Clinic I (16:00- 18:00)
    17:15-17:30 Roger Barker, University of Cambridge, U.K.
    LESSONS LEARNED FROM A CELL-BASED TRIAL IN PARKINSON’S DISEASE


    17:30-17:55 Silviu Itescu, Mesoblast LTD., Australia
    ROAD TO THE CLINIC: THE COMMERCIALIZATION OF MESENCHYMAL LINEAGE CELLS



    Concurrent IID: Tissue Engineering (16:00- 18:00)
    Session Chair: Mattias Lutolf, École Polytechnique Fédérale de Lausanne (EFPL), Switzerland
    16:00 – 16:05 Topic Overview by Chair


    Friday, 22 June
    Plenary IV: New Technologies in Stem Cell Engineering
    9:00 to 9:25: Fred H. Gage, Salk Institutes for Biological Studies, U.S.
    IN VIVO BRAIN ORGANOID MODEL OF VASCULARIZED AND FUNCTIONAL PSC-DERIVED HUMAN BRAIN ORGANOIDS


    Saturday, 22 June
    Plenary VI: Cancer Stem Cells
    10:40 – 11:05: Leonard I. Zon, Boston Children's Hospital, U.S.
    THE START OF CANCER - STEM CELL CHANGES, CLONAL EXPANSION AND NICHE REGULATION
    Concurrent IVA: Road to the Clinic 2 (13:15 to 15:15)
    Session Chair: Robert Deans, BlueRock Therapeutics, U.S.
    13:15 – 13:20 Topic Overview by Chair

    Concurrent IVB: Epigenetics and Genetic Regulatory Networks
    13:20-13:45: Jose Polo, Monash University, Australia
    CHROMATIN AND TRANSCRIPTION FACTOR DYNAMICS DURING REPROGRAMMING

    ISSCR.PNG
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$2.31
Change
-0.100(4.15%)
Mkt cap ! $2.956B
Open High Low Value Volume
$2.33 $2.35 $2.15 $30.94M 13.57M

Buyers (Bids)

No. Vol. Price($)
5 75954 $2.30
 

Sellers (Offers)

Price($) Vol. No.
$2.32 10350 2
View Market Depth
Last trade - 16.17pm 21/07/2025 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.